These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 16151384)

  • 1. The problem with potency.
    Scott CT
    Nat Biotechnol; 2005 Sep; 23(9):1037-9. PubMed ID: 16151384
    [No Abstract]   [Full Text] [Related]  

  • 2. New therapeutic strategies for cell-mediated autoimmune diseases.
    Goldman M
    Acta Neurol Belg; 1994; 94(2):89-91. PubMed ID: 7913569
    [No Abstract]   [Full Text] [Related]  

  • 3. CTLA-4 blockade: autoimmunity as treatment.
    Kapadia D; Fong L
    J Clin Oncol; 2005 Dec; 23(35):8926-8. PubMed ID: 16204008
    [No Abstract]   [Full Text] [Related]  

  • 4. CD20: a target antigen for immunotherapy of autoimmune diseases.
    Perosa F; Favoino E; Caragnano MA; Prete M; Dammacco F
    Autoimmun Rev; 2005 Nov; 4(8):526-31. PubMed ID: 16214090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of immunostimulatory monoclonal antibodies.
    Gray JC; Johnson PW; Glennie MJ
    Clin Sci (Lond); 2006 Aug; 111(2):93-106. PubMed ID: 16831129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmune Cardiotoxicity of Cancer Immunotherapy.
    Cheng F; Loscalzo J
    Trends Immunol; 2017 Feb; 38(2):77-78. PubMed ID: 27919707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are mimotope vaccines a good alternative to monoclonal antibodies?
    Pourjafar M; Samadi P; Khoshinani HM; Saidijam M
    Immunotherapy; 2019 Jun; 11(9):795-800. PubMed ID: 31094256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell targeted immunotherapy for autoimmune disease.
    Lee E; Sinha AA
    Autoimmunity; 2005 Dec; 38(8):577-96. PubMed ID: 16390811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical application of monoclonal antibodies].
    Yata J
    Ryumachi; 1984 Aug; 24(4):288-94. PubMed ID: 6393366
    [No Abstract]   [Full Text] [Related]  

  • 10. -ximab this and -zumab that! Has the magic bullet arrived in the new millennium of medicine and science?
    Ballow M
    J Allergy Clin Immunol; 2005 Oct; 116(4):738-43. PubMed ID: 16210044
    [No Abstract]   [Full Text] [Related]  

  • 11. Anticytotoxic T lymphocyte-associated antigen 4 treatment--can melanoma be cured at the expense of autoimmune disorders?
    Lejeune FJ
    Melanoma Res; 2006 Oct; 16(5):377-8. PubMed ID: 17013085
    [No Abstract]   [Full Text] [Related]  

  • 12. Immune intervention with monoclonal antibodies targeting CD152 (CTLA-4) for autoimmune and malignant diseases.
    Chin LT; Chu C; Chen HM; Wang DW; Liao SK
    Chang Gung Med J; 2008; 31(1):1-15. PubMed ID: 18419049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Targeted immunotherapy against interleukin 2 receptors (IL-2R)--an attempt at synthesis].
    Sabliński T; Wasik MA; Tilney NL; Kupiec-Wegliński JW
    Postepy Hig Med Dosw; 1992; 46(3):275-85. PubMed ID: 1293580
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer immunotherapy.
    Schuster M; Nechansky A; Kircheis R
    Biotechnol J; 2006 Feb; 1(2):138-47. PubMed ID: 16892244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccination with cytokines in autoimmune diseases.
    Delavallée L; Assier E; Denys A; Falgarone G; Zagury JF; Muller S; Bessis N; Boissier MC
    Ann Med; 2008; 40(5):343-51. PubMed ID: 18484346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of immunotherapeutic agents.
    Hadden JW
    Dev Biol Stand; 1992; 77():5-15. PubMed ID: 1426673
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunotherapy for neurological diseases.
    Villoslada P; Moreno B; Melero I; Pablos JL; Martino G; Uccelli A; Montalban X; Avila J; Rivest S; Acarin L; Appel S; Khoury SJ; McGeer P; Ferrer I; Delgado M; Obeso J; Schwartz M
    Clin Immunol; 2008 Sep; 128(3):294-305. PubMed ID: 18534912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune therapies of autoimmune diseases: are we approaching a real cure?
    Chatenoud L
    Curr Opin Immunol; 2006 Dec; 18(6):710-7. PubMed ID: 17011768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory therapies and the risk of opportunistic infections.
    Johnson DE; Smith DA; Park BK
    Curr Opin Drug Discov Devel; 2010 Jan; 13(1):20-2. PubMed ID: 20047142
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of immunotherapy with anti-L3T4 monoclonal antibody on autoimmune cardiomyopathy: experiment with mice].
    Yuan J; Liao YH; Wang ZH; Cheng X; Zhang JH; Dong JH; Wang M
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3346-9. PubMed ID: 16409842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.